Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.29
-5.5%
$1.40
$0.90
$3.49
$68.51M-0.9741,310 shs96,866 shs
CORBF
Global Cord Blood
$0.55
-59.3%
$1.00
$0.25
$2.00
$66.85M-0.6100,435 shs3,816 shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$7.33
-1.5%
$6.71
$5.93
$9.81
$288.57M1.33338,969 shs307,062 shs
Exagen Inc. stock logo
XGN
Exagen
$9.67
+1.2%
$7.54
$2.38
$9.75
$210.35M1.61409,119 shs147,214 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
+0.74%-2.84%-7.93%-34.76%-43.85%
CORBF
Global Cord Blood
-59.26%-59.26%-26.67%-47.62%-68.57%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
+2.06%+17.72%+10.39%+8.30%+5.38%
Exagen Inc. stock logo
XGN
Exagen
+1.92%+7.78%+36.77%+64.26%+184.52%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.5284 of 5 stars
0.05.00.00.01.90.00.0
CORBF
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
2.7678 of 5 stars
0.05.00.00.02.53.31.3
Exagen Inc. stock logo
XGN
Exagen
4.1857 of 5 stars
3.52.00.04.52.02.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
CORBF
Global Cord Blood
0.00
N/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.00
N/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
3.00
Buy$11.2516.34% Upside

Current Analyst Ratings Breakdown

Latest ATPC, VMD, XGN, and CORBF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$10.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $11.00
7/30/2025
Exagen Inc. stock logo
XGN
Exagen
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$12.00
7/23/2025
Exagen Inc. stock logo
XGN
Exagen
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$12.00
5/15/2025
Exagen Inc. stock logo
XGN
Exagen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
5/15/2025
Exagen Inc. stock logo
XGN
Exagen
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$8.00 ➝ $7.00
5/13/2025
Exagen Inc. stock logo
XGN
Exagen
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M49.02N/AN/A$0.48 per share2.70
CORBF
Global Cord Blood
$196.12M0.34$0.39 per share1.40N/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$224.26M1.27$0.93 per share7.91$3.65 per share2.01
Exagen Inc. stock logo
XGN
Exagen
$55.64M3.82N/AN/A$0.96 per share10.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.60N/AN/A-191.34%-30.95%-27.00%8/13/2025 (Estimated)
CORBF
Global Cord Blood
$79.04MN/A0.00N/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$11.27M$0.3421.56N/A5.80%10.38%7.88%N/A
Exagen Inc. stock logo
XGN
Exagen
-$15.11M-$0.89N/AN/AN/A-28.85%-130.38%-34.69%N/A

Latest ATPC, VMD, XGN, and CORBF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.01N/A-$0.01N/AN/A
8/6/2025Q2 2025
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$0.0850$0.08-$0.0050$0.08$63.50 million$63.06 million
7/29/2025Q2 2025
Exagen Inc. stock logo
XGN
Exagen
-$0.18-$0.18N/A-$0.21$16.25 million$17.20 million
5/15/2025Q1 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/A
Exagen Inc. stock logo
XGN
Exagen
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
24.68
24.64
CORBF
Global Cord Blood
N/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.02
1.48
1.37
Exagen Inc. stock logo
XGN
Exagen
1.06
4.95
4.95

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
CORBF
Global Cord Blood
N/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
74.24%
Exagen Inc. stock logo
XGN
Exagen
75.25%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
CORBF
Global Cord Blood
0.50%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
20.00%
Exagen Inc. stock logo
XGN
Exagen
12.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
CORBF
Global Cord Blood
1,200121.55 millionN/ANot Optionable
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
1,17938.79 million31.03 millionNot Optionable
Exagen Inc. stock logo
XGN
Exagen
22022.00 million19.23 millionOptionable

Recent News About These Companies

BTIG Sticks to Their Buy Rating for Exagen (XGN)
What is KeyCorp's Forecast for Exagen Q3 Earnings?
Exagen (XGN) Receives a Buy from Craig-Hallum
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
Keybanc Upgrades Exagen (XGN)
Exagen Q2 Revenue Jumps 14 Percent
Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript
Exagen Inc. Reports Strong Q2 2025 Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.29 -0.08 (-5.55%)
Closing price 03:59 PM Eastern
Extended Trading
$1.28 -0.01 (-1.08%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Global Cord Blood NYSE:CORBF

$0.55 -0.80 (-59.26%)
As of 02:40 PM Eastern

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Viemed Healthcare stock logo

Viemed Healthcare NASDAQ:VMD

$7.33 -0.11 (-1.48%)
Closing price 04:00 PM Eastern
Extended Trading
$7.33 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Exagen stock logo

Exagen NASDAQ:XGN

$9.67 +0.11 (+1.15%)
Closing price 04:00 PM Eastern
Extended Trading
$9.72 +0.05 (+0.52%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.